Congratulations to Maria Amaya, MD, PhD, Assistant Professor of Medicine-Hematology (and CU HemeOnc Fellowship alumni) on being selected as one of the 2025 Translational Research Scholars. Each scholar receives research support over four years. #CUAnschutz #CUCancer

Although our understanding of cancer is greater than at any other point in history, cancer continues to be a leading cause of death due to lack of intervention. #worldcancerday allows us to come together to raise awareness about cancer risks, prevention, detection, & treatment. #cucancer #cuanschutz

This week we celebrate our outstanding housestaff and their dedication, tireless efforts, and unwavering commitment to patient care. Thank you for all you do - we are incredibly grateful for your hard work and the future of medicine you represent. #CUAnschutz #CUCancer

Break Through Cancer - Launching the PoweRD 2 Cure ALK+ Lung Cancer TeamLab - OncoDaily Break Through Cancer - Launching the PoweRD 2 Cure ALK+ Lung Cancer TeamLab / Boston Children’s Hospital, Break Through Cancer, cancer, CU Cancer Center,

Break Through Cancer – Launching the PoweRD 2 Cure ALK+ Lung Cancer TeamLab

oncodaily.com/blog/break-t...

@break-cancer.bsky.social

#Cancer #CUCancer #OncoDaily #Oncology #BostonChildrensHospital #Medicine #Health

It's a match! We are beyond excited for the newest class of HemeOnc fellows to join us in July 2025! #MatchDay2024 #CUAnschutz #CUCancer

Passions for Medical Science and Family: A Fellow Stays Focused on her Goals ‘We need more women as physician scientists,’ says hematology-oncology fellow Natalie Longino, MD, PhD, who explores the secrets of cancer.

First year HemeOnc fellow, Natalie Longino, MD, PhD, recently sat down with the CU Department of Medicine to discuss her career in medicine and passion for cancer research. Be sure to read the full article! #CUCancer #CUAnschutz #CUDeptofMedicine

Happy Thanksgiving to you and yours from the CU HemeOnc Fellowship! #CUAnschutz #CUCancer #HappyThanksgiving 🦃